Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIF antisense RNA 2 (LIF-AS2) is a long non-coding RNA (lncRNA) gene found in humans, transcribed antisense to nearby coding or non-coding regions, and is classified as an antisense RNA. Antisense RNAs such as LIF-AS2 can regulate gene expression at multiple levels, including transcription, splicing, and translation, often by forming RNA-RNA duplexes with complementary mRNA targets or influencing local chromatin state. The LIF-AS2 gene (HGNC:28298, NCBI Gene: 91370) is located on chromosome 22. While LIF-AS2 belongs to a broader class of lncRNAs implicated in cancer and other diseases, no evidence indicates that it encodes a protein or functions as a traditional therapeutic target, receptor, enzyme, or transporter[1][3][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIF antisense RNA 2 (LIF-AS2).